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Abstract
Objectives
Currently, limited data examines the safety of utilizing fat transfers 
in the setting of malignant parotid disease. Here we evaluate the 
safety of fat graft reconstruction of parotidectomy defects in the 




Electronic chart review of patients who underwent parotidectomy 
from 2012-2020 were reviewed. 
Results
Three hundred and sixty-one patients were identified at a single 
institution who underwent parotidectomy, and 113 (31.3%) were for 
malignancy. One hundred and thirty-two patients underwent fat graft 
reconstruction (49.2%, n=65 for umbilical, 50.8%, n=67 for dermal). 
One-third of patients had malignant pathology (34.8%, n=46). The 
most common malignant tumors were squamous cell carcinoma 
(n=15), acinic cell carcinoma (n=9), and mucoepidermoid carcinoma 
(n=6). Twenty patients (45.5%) received postoperative radiation 
therapy. Complications included: surgical site necrosis (13%), 
hematoma (4.3%), and infection (2.2%). Overall incidence of 
malignant recurrence was 4.4% with a mean time of follow-up of 
10.3 (range 0 – 77.3) months. Incidence of malignant recurrence in 
the fat graft reconstruction subset was 0% with a mean follow-up of 
9.8 (range 0.2 – 49.3) months. There was no association with use of 
fat graft and recurrence (p>0.05).
Conclusion
Parotidectomy defects for malignant neoplasms can be reconstructed 
with fat graft transfers with no impact on surveillance for disease 
recurrence.
Introduction
• Parotidectomy can result in a visible postoperative deformity, 
causing patient dissatisfaction and cosmetic morbidity1
• Several options exist for reconstruction, such as a superficial 
musculoaponeurotic system (SMAS) flap, free tissue transfer, and 
dermal matrix materials2
• Fat is comparable to parotid tissue in consistency, causing it to be 
a suitable replacement graft
• Objective of this study it to examine the safety of fat graft for 
parotidectomy defect reconstruction in the malignant setting
Methods
• Retrospective cohort study of patients receiving parotidectomy 
between August 2012 and June 2020 at a single academic 
institution
• Charts were reviewed for demographic, surgical, pathologic, and 
post-operative course
• Patients were tracked for follow-up with special attention for 
recurrence
• Categorical variables were compared utilizing a Fisher Exact Test
Results
Discussion
• Previous studies have reported that fat reconstruction of 
parotidectomy defects accomplishes a consistent long-standing 
aesthetic outcome3
• Our results suggest no increased risk of surveillance in the use of 
fat graft in the context of malignant parotid disease
• The most common complication in our patient cohort was surgical 
site necrosis
• Short-term results are encouraging but long-term surveillance may 
be necessary
Conclusion
• Parotidectomy defects for malignant disease can be safely and 
effectively reconstructed with fat transfers, with no negative 
impact on surveillance for disease recurrence
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Figure 1: Flow Chart of Patient Population
Table 1: Characteristics of Malignant Parotidectomy Procedures 
Reconstructed with Fat Graft
• Of 361 patients who underwent parotidectomy, 113 (31.3%) had 
malignant pathology
• Average follow-up for malignant disease: 10.3 months (range: 0 –
77.3 months)
• Average follow-up within fat graft subset: 9.76 months 
(range: 0.2 – 49.3 months)
• Overall recurrence rate: 4.4% (n=5)
• Recurrence rate within fat graft subset: 0%
• No association between use of fat graft and rate of recurrent 
disease (p>0.05)
361 patients underwent 
parotidectomy
113 parotidectomies for 
malignant disease




248 parotidectomies for 
benign disease
67 reconstructive methods 
w/o fat graft (SMAS Flap, 
ALTFF, Cervicofacial 
Advacement Flap)
5 patients experienced 
recurrence
Characteristic # of Patients (%)
Female Gender 25 (54.3)
Mean Age (years) 60.9 (range: 15.4-82.4)
Tumor Type
        Squamous Cell Carcinoma 15 (32.6)
        Acinic Cell Carcinoma 9 (19.6)
        Mucoepidermoid Carcinoma 6 (13.0)
        Other (Melanoma, Lymphoma, etc) 16 (34.8)
Concurrent Neck Dissection 24 (52.2)
Facial Nerve Sacrifice and Reconstruction 9 (19.6)
Facial Nerve Weakness 13 (28.3)
Surgical Site Necrosis 6 (13.0)
Hematoma 2 (4.3)
Post-operative Infection 1 (2.2)
First Bite Syndrome 1 (2.2)
Post-operative Radiation 20 (45.5)
Post-operative Chemotherapy 5 (11.4)
